thyroxine has been researched along with Xerostomia in 4 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Xerostomia: Decreased salivary flow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to examine the incidence of sialadenitis and xerostomia within a year after radioactive iodine administration for thyroid remnant ablation after preparation with recombinant human thyroid-stimulating hormone (rhTSH) or levothyroxine (LT4 ) withdrawal." | 5.22 | Effect of recombinant human thyroid-stimulating hormone or levothyroxine withdrawal on salivary gland dysfunction after radioactive iodine administration for thyroid remnant ablation. ( Giannoula, E; Goulis, DG; Iakovou, I; Katsikaki, G; Konstantinidis, I; Tsinaslanidou, Z, 2016) |
| " Xerostomia severity was higher among females, or individuals taking: (1) an anginal at baseline and five years, (2) an anginal without a concomitant betablocker at five years, (3) thyroxine and a diuretic at five years, or (4) antidepressants or antiasthma drugs at both baseline and at five years." | 3.70 | Medication and dry mouth: findings from a cohort study of older people. ( Chalmers, JM; Slade, GD; Spencer, AJ; Thomson, WM, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glick, A | 1 |
| Sista, V | 1 |
| Johnson, C | 1 |
| Muralidharan, D | 1 |
| Fareed, N | 1 |
| Pradeep, PV | 1 |
| Margabandhu, S | 1 |
| Ramalingam, K | 1 |
| Ajith Kumar, BV | 1 |
| Iakovou, I | 1 |
| Goulis, DG | 1 |
| Tsinaslanidou, Z | 1 |
| Giannoula, E | 1 |
| Katsikaki, G | 1 |
| Konstantinidis, I | 1 |
| Thomson, WM | 1 |
| Chalmers, JM | 1 |
| Spencer, AJ | 1 |
| Slade, GD | 1 |
1 trial available for thyroxine and Xerostomia
| Article | Year |
|---|---|
Effect of recombinant human thyroid-stimulating hormone or levothyroxine withdrawal on salivary gland dysfunction after radioactive iodine administration for thyroid remnant ablation.
Topics: Adult; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Recombinant Proteins; Salivary Gland | 2016 |
3 other studies available for thyroxine and Xerostomia
| Article | Year |
|---|---|
Oral Manifestations of Commonly Prescribed Drugs.
Topics: Albuterol; Amlodipine; Anticonvulsants; Antihypertensive Agents; Atorvastatin; Bisphosphonate-Associ | 2020 |
Qualitative and quantitative changes in saliva among patients with thyroid dysfunction prior to and following the treatment of the dysfunction.
Topics: Adolescent; Adult; Antibodies; Antithyroid Agents; Autoantigens; Buffers; Carbimazole; Female; Follo | 2013 |
Medication and dry mouth: findings from a cohort study of older people.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Antidepressive Agents; | 2000 |